|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Gefriderm
|
|
Active substances:
|
|
|
ATC code:
|
QD07CA87
|
|
Dosage form:
|
cutaneous spray, solution
|
|
Strength:
|
0,926mg+1,025mg+2,041mg 1ml
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated December 1, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated December 1, 2020)
|
|
Labelling:
|
(last updated December 1, 2020)
|
|
Indication:
|
Treatment of acute superficial dermatitis caused by mixed infections with Pseudomonas aeruginosa or Staphylococcus pseudintermedius susceptible to marbofloxacin and Malassezia pachydermatis susceptible to ketoconazole. The indication is limited to focal skin infections (e.g. hot spots, intertrigo, superficial folliculitis).
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Alpha-Vet Kft.
|
|
Marketing authorization number:
|
2263
|
|
Marketing authorization issued on:
|
December 1, 2020
|
|
Marketing authorization expires on:
|
December 1, 2025
|
|
Marketing authorization procedure type:
|
Decentralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1799095
|
Gefriderm
|
cutaneous spray, solution
|
0,926mg +1,025mg +2,041mg 1ml 30ml 1TK
|
Prescription
|
|
|
17.05.2023
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere